Physician profile
Patrick Gilligan
NPI 1043638802
$5,903.07
in general payments reported to CMS, 2019-2025
11 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,680 · 2021: $127 · 2022: $794 · 2023: $657 · 2024: $1,005 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188 · Travel and Lodging: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,187.64 |
| Travel and Lodging | $1,114.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,106.53 | 2020-2025 | Mako, Triathlon, Accolade |
| Heraeus Medical, LLC. | $1,416.62 | 2020 | |
| Smith+Nephew, INC. | $523.97 | 2020-2024 | Evos |
| Zimmer Biomet Holdings, INC. | $394.48 | 2022-2025 | G7, Persona |
| Becton, Dickinson and Company | $202.20 | 2024 | Arista Ah Flexitip |
| Davol INC. | $143.68 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $33.74 | 2025 | |
| Bioventus LLC | $26.43 | 2025 | Durolane |
| Medline Industries Lp | $26.29 | 2023 | |
| Medtronic, INC. | $17.11 | 2024 | V-Loc 180 |
| Avanos Medical | $12.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gilligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.